WS #10050

20:38→21:02 UTC

From 500 msgs · 5 key-dev

Johnson & Johnson buys degradre ADC tech for oncology; CEO says focused on cancer, not obesity drugs.

J&J Oncology Focus

Johnson & Johnson buys degradre ADC tech for oncology; CEO says focused on cancer, not obesity drugs.